In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Shire Pharmaceuticals is buying Roberts Pharmaceuticals (in-licenses drugs) in a $980mm stock swap that values each Roberts common share at about $30.71, a (pr)26% premium to its 10-day pre-announcement trading average. Post merger, Shire shareholders will hold 56% of the new company, and Roberts' will control the rest. The deal is expected to close in the fourth quarter of 1999.
Payment Includes Stock
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?